StockData
Shuttle Pharmaceuticals Holdings, Inc. logo

Shuttle Pharmaceuticals Holdings, Inc. (SHPH) stock

SHPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Sep 24, 2026Score 5/30
$4.24−0.29 (-6.40%)

Close on Nov 16, 2026Market cap $4.24MP/E –Yield –

Shuttle Pharmaceuticals total assets

Total assets on the balance sheet at the end of each period.

Shuttle Pharmaceuticals's total assets was $22.81M at Jun 30, 2026. For fiscal 2025 it was $10.48M, up 318.0% from the year before. The highest annual figure on record is $10.48M in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$10.48M+318.0%
FY2024Dec 31, 2024$2.51M-57.9%
FY2023Dec 31, 2023$5.95M-31.2%
FY2022Dec 31, 2022$8.65M+1228.0%
FY2021Dec 31, 2021$651.64K–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$22.81M+314.4%
Q1 FY2026Mar 31, 2026$11.81M+122.4%
Q4 FY2025Dec 31, 2025$10.48M+318.0%
Q3 FY2025Sep 30, 2025$3.54M+426.0%
Q2 FY2025Jun 30, 2025$5.50M+95.7%
Q1 FY2025Mar 31, 2025$5.31M+11.7%
Q4 FY2024Dec 31, 2024$2.51M-57.9%
Q3 FY2024Sep 30, 2024$673.57K-90.9%
Q2 FY2024Jun 30, 2024$2.81M-68.2%
Q1 FY2024Mar 31, 2024$4.75M-54.4%
Q4 FY2023Dec 31, 2023$5.95M-31.2%
Q3 FY2023Sep 30, 2023$7.38M-21.4%
Q2 FY2023Jun 30, 2023$8.84M+1256.1%
Q1 FY2023Mar 31, 2023$10.44M–
Q4 FY2022Dec 31, 2022$8.65M–
Q3 FY2022Sep 30, 2022$9.38M–
Q4 FY2021Dec 31, 2021$651.64K–

More Shuttle Pharmaceuticals figures

See a number that looks wrong?